Published in Ann Transplant on March 25, 2011
Oxidative stress, DNA damage and repair in heart failure patients after implantation of continuous flow left ventricular assist devices. Int J Med Sci (2013) 0.86
Combined Ventricular Assist Device Placement With Adjustable Gastric Band (VAD-BAND): A Promising New Technique for Morbidly Obese Patients Awaiting Potential Cardiac Transplantation. J Clin Med Res (2012) 0.75
Reproducibility of proximal isovelocity surface area, vena contracta, and regurgitant jet area for assessment of mitral regurgitation severity. JACC Cardiovasc Imaging (2010) 1.89
Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury. Cardiovasc Res (2005) 1.78
Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. Eur Heart J (2004) 1.77
Noninvasive, near infrared spectroscopic-measured muscle pH and PO2 indicate tissue perfusion for cardiac surgical patients undergoing cardiopulmonary bypass. Crit Care Med (2003) 1.49
Changes in left and right ventricular function of donor hearts during the first year after heart transplantation. Heart (2011) 1.47
Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome. Catheter Cardiovasc Interv (2008) 1.44
Heart-rate adjustment of transcatheter haemodynamics improves the prognostic evaluation of paravalvular regurgitation after transcatheter aortic valve implantation. EuroIntervention (2015) 1.41
Persistent sexual dysfunction impairs quality of life after cardiac transplantation. J Sex Med (2010) 1.38
Pilot study of palliative care consultation in patients with advanced heart failure referred for cardiac transplantation. J Palliat Med (2012) 1.06
Left main coronary artery thrombus: a case series with different outcomes. J Thromb Thrombolysis (2005) 1.06
Impact of dietary patterns and interventions on cardiovascular health. Circulation (2006) 1.05
A novel minimal-invasive model of chronic myocardial infarction in swine. Coron Artery Dis (2004) 1.00
Coxibs and heart disease: what we have learned and what else we need to know. J Am Coll Cardiol (2006) 0.98
Left ventricular noncompaction cardiomyopathy: updated review. Ther Adv Cardiovasc Dis (2013) 0.98
Intrinsic cardiac origin of human cardiosphere-derived cells. Eur Heart J (2011) 0.93
Repeated assessment of coronary flow velocity pattern in patients with first acute myocardial infarction. J Am Coll Cardiol (2002) 0.93
Induction therapy with thymoglobulin after heart transplantation: impact of therapy duration on lymphocyte depletion and recovery, rejection, and cytomegalovirus infection rates. J Heart Lung Transplant (2008) 0.92
Administration of vascular endothelial growth factor adjunctive to fetal cardiomyocyte transplantation and improvement of cardiac function in the rat model. J Cardiovasc Pharmacol Ther (2005) 0.92
Aortic annular sizing for transcatheter aortic valve replacement using cross-sectional 3-dimensional transesophageal echocardiography. J Am Coll Cardiol (2013) 0.90
"How do cardiomyocytes die?" apoptosis and autophagic cell death in cardiac myocytes. J Card Fail (2006) 0.89
The dilemma, causes and approaches to avoid recurrent hospital readmissions for patients with chronic heart failure. Heart Fail Rev (2012) 0.89
Self-efficacy mediates the associations of social support and depression with treatment adherence in heart failure patients. Int J Behav Med (2013) 0.89
Predictors of re-hospitalization in patients with chronic heart failure. World J Cardiol (2012) 0.88
Value of medical therapy in patients >80 years of age with heart failure and preserved ejection fraction. Am J Cardiol (2009) 0.87
How does the heart (not) die? The role of autophagy in cardiomyocyte homeostasis and cell death. Heart Fail Rev (2010) 0.87
Depression and anxiety predict decline in physical health functioning in patients with heart failure. Ann Behav Med (2011) 0.87
Esophageal motor dysfunction and gastroesophageal reflux are prevalent in lung transplant candidates. Ann Thorac Surg (2010) 0.86
Transplantation of fetal cardiomyocytes into infarcted rat hearts results in long-term functional improvement. Tissue Eng (2004) 0.84
The potential effects of IGF-1 and GH on patients with chronic heart failure. J Cardiovasc Pharmacol Ther (2011) 0.84
The effects of spirituality and religion on outcomes in patients with chronic heart failure. J Relig Health (2012) 0.84
Failing the failing heart: a review of palliative care in heart failure. Rev Cardiovasc Med (2013) 0.84
Statin therapy in patients with diastolic heart failure. Clin Cardiol (2010) 0.84
The relationship between erectile dysfunction and cardiovascular disease. Part II: The role of PDE-5 inhibition in sexual dysfunction and cardiovascular disease. Rev Cardiovasc Med (2008) 0.83
Avoidant coping moderates the association between anxiety and patient-rated physical functioning in heart failure patients. J Behav Med (2011) 0.82
Erythropoiesis stimulating agents in heart failure patients with anemia: a meta-analysis. Cardiovasc Drugs Ther (2009) 0.82
Complicated ruptured sinus of Valsalva: cardiac computed tomographic angiography (64 slice) predicts surgical appearance and obviates need for invasive cardiac catheterization. Interact Cardiovasc Thorac Surg (2009) 0.82
Evaluation of the prevalence and severity of pain in patients with stable chronic heart failure. World J Cardiol (2012) 0.81
Histopathology and transmurality of acute microwave lesions on the beating human atrium. Interact Cardiovasc Thorac Surg (2006) 0.81
Heart transplantation using bivalirudin as anticoagulant. Interact Cardiovasc Thorac Surg (2009) 0.81
Clinical Review: Is the perioperative use of beta-blockers still recommended? A critical review of recent controversies. J Cardiovasc Pharmacol Ther (2009) 0.81
Pregnancy-associated spontaneous coronary artery dissection. Am J Obstet Gynecol (2007) 0.80
Syncope in adults: systematic review and proposal of a diagnostic and therapeutic algorithm. Int J Cardiol (2011) 0.80
H1N1 virus infection associated with acute myocardial infarction in a young patient without coronary artery disease--first reported case. Acta Cardiol (2011) 0.79
Left ventricular assist device placement in a patient with end-stage heart failure and human immunodeficiency virus. Interact Cardiovasc Thorac Surg (2009) 0.79
Benefits, unresolved questions, and technical issues of cardiac resynchronization therapy for heart failure. Am J Cardiol (2005) 0.79
Maximal care considerations when treating patients with end-stage heart failure: ethical and procedural quandaries in management of the very sick. J Relig Health (2011) 0.79
Tadalafil as monotherapy and in combination regimens for the treatment of pulmonary arterial hypertension. Ther Adv Respir Dis (2012) 0.79
Role of transesophageal echocardiography guided cardioversion in patients with atrial fibrillation, previous left atrial thrombus and effective anticoagulation. Int J Cardiol (2006) 0.79
The first year post-heart transplantation: use of immunosuppressive drugs and early complications. J Cardiovasc Pharmacol Ther (2008) 0.79
Myths and truths of growth hormone and testosterone therapy in heart failure. Expert Rev Cardiovasc Ther (2011) 0.78
Vasopressin antagonism: a future treatment option in heart failure. Eur Heart J (2005) 0.78
Is vitamin D deficiency associated with heart failure? A review of current evidence. J Cardiovasc Pharmacol Ther (2011) 0.78
The relationship between erectile dysfunction and cardiovascular disease. Part I: pathophysiology and mechanisms. Rev Cardiovasc Med (2007) 0.78
Ultrafiltration for the management of acute decompensated heart failure. J Card Fail (2008) 0.78
Andropause and the development of cardiovascular disease presentation-more than an epi-phenomenon. J Geriatr Cardiol (2011) 0.77
Review article: the new concept of interventional heart failure therapy--part 1: electrical therapy, treatment of CAD, fluid removal, and ventricular support. J Cardiovasc Pharmacol Ther (2010) 0.77
Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients--the IMPROVED multi-centre study. Eur Heart J (2004) 0.77
Growth hormone and testosterone in heart failure therapy. Expert Opin Pharmacother (2010) 0.77
The new concept of ''interventional heart failure therapy'': part 2--inotropes, valvular disease, pumps, and transplantation. J Cardiovasc Pharmacol Ther (2010) 0.77
Testosterone therapy: treatment of metabolic disturbances in heart failure. J Cardiovasc Pharmacol Ther (2010) 0.77
Successful bilateral lung transplant outcomes in recipients 61 years of age and older. Transplantation (2006) 0.77
The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension. Vasc Health Risk Manag (2010) 0.77
Update on the safety of testosterone therapy in cardiac disease. Expert Opin Drug Saf (2011) 0.77
Transthoracic echocardiographic parameters in the estimation of pulmonary capillary wedge pressure in patients with present or previous heart failure. Am J Cardiol (2012) 0.76
An evaluation of the prevalence and severity of pain and other symptoms in acute decompensated heart failure. J Palliat Med (2012) 0.76
Value of color Doppler three-dimensional transesophageal echocardiography in the percutaneous closure of mitral prosthesis paravalvular leak. Am J Cardiol (2010) 0.76
Impact of obesity in patients with congestive heart failure. Rev Cardiovasc Med (2009) 0.76
Heart transplantation in the elderly: why cardiac transplantation does not need to be limited to younger patients but can be safely performed in patients above 65 years of age. Ann Transplant (2010) 0.76
Periprocedural adverse events in cell therapy trials in myocardial infarction and cardiomyopathy: a systematic review. Clin Res Cardiol (2012) 0.75
Vineberg procedure for inadvertent injury to anomalous left anterior descending artery during tetralogy of fallot repair: four decades later. Tex Heart Inst J (2006) 0.75
The prognostic value of anemia in patients with diastolic heart failure. Tex Heart Inst J (2009) 0.75
Sexual function in women with heart disease and coronary artery disease. Int J Impot Res (2007) 0.75
Sexual dysfunction in cardiac rehabilitation patients is much more than simply an epiphenomenon and needs more study. Rev Esp Cardiol (2008) 0.75
Does the United States economy affect heart failure readmissions? A single metropolitan center analysis. Clin Cardiol (2012) 0.75
Heart allograft transplanted twice. Eur J Cardiothorac Surg (2008) 0.75
Philosophical implications of the systemic and patient-oriented management of chronic heart failure. J Relig Health (2011) 0.75
Clinical applications of bivalirudin in the cardiac catheterization laboratory. J Cardiovasc Pharmacol Ther (2010) 0.75
An agonist of liver X receptor slows valvular disease in a hypercholesterolemia mouse model. J Heart Valve Dis (2010) 0.75
Heart failure therapy: beyond the guidelines. J Cardiovasc Med (Hagerstown) (2010) 0.75
Palliative care issues in heart transplant candidates. Curr Opin Support Palliat Care (2015) 0.75
The beneficial role of spiritual counseling in heart failure patients. J Relig Health (2014) 0.75
Erectile dysfunction as a complication of heart failure. Curr Heart Fail Rep (2010) 0.75
Improved erectile function after cardiac resynchronization therapy in a patient with heart failure-a case report. J Sex Med (2009) 0.75